Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Ryu Elly, Officier. Director active across 1 company, notably Sesen Bio, Inc.. Cumulatively, 4 filings have been published. Split: 0 buy · 2 sells. Total volume traded: €13k. Activity tracked since 1 October 2021. The latest transaction was disclosed on 2 March 2023 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
4 of 4 declarations
Elly Ryu is Principal Accounting Officer of Sesen Bio, Inc. In this role, she oversees the company's accounting operations. Sesen Bio is a biopharmaceutical company specializing in developing innovative treatments. Elly plays a crucial role in financial management and accounting compliance.